FDA Adverse Event Death Summary report: N

HEMOLUNG CATHETER KIT

MDR report key: 6602757 · Received May 31, 2017

Report

Report Number
3009763347-2017-00007
Event Type
Death
Date Received
May 31, 2017
Date of Event
April 2, 2016
Report Date
May 31, 2017
Manufacturer
ALUNG TECHNOLOGIES, INC.
Product Code
DQR
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

THIS REPORT IS A RESULT OF (B)(4) AND ECPORTER RECEIVING A 483 FILE NUMBER (B)(4) - OBSERVATION 1. THE SUMMARY OF THE EVENT IS AS FOLLOWS: AFTER MULTIPLE ATTEMPTS TO RETRIEVE INFORMATION FROM THE TREATING PHYSICIAN, (B)(4) RECEIVED THE HEMOLUNG REGISTRY FORM FROM DR. (B)(6), ON (B)(6) 2016. THE PHYSICIAN INDICATED THAT THE CEREBRAL HEMORRHAGE AND SUBSEQUENT DEATH WERE DEFINITELY RELATED TO HEMOLUNG THERAPY SECONDARY TO THE NEED FOR ANTICOAGULATION. DR. (B)(6) INDICATED THE HEMOLUNG DEVICE WAS FUNCTIONING AS EXPECTED ALLOWING FOR IMPROVED LUNG PROTECTIVE VENTILATION WITH DESIRED CO2 REMOVAL. OUT OF AN ABUNDANCE OF CAUTION, (B)(4) IS REPORTING THIS INCIDENT. MORE INFORMATION IS ATTEMPTED TO BE GATHERED FROM DR. (B)(6) AT THIS TIME. HEMORRHAGE IS, AGAIN, A KNOWN COMPLICATION OF ANY EXTRACORPOREAL DEVICE, INCLUDING THE HEMOLUNG RAS, DUE TO THE REQUIRED NEED OF HEPARIN FOR ANTICOAGULATION PURPOSES. THESE COMPLICATIONS ARE COVERED IN HEMOLUNG TRAININGS AND ARE LABELED APPROPRIATELY IN THE POTENTIAL COMPLICATIONS SECTION OF THE HEMOLUNG RAS INSTRUCTIONS FOR USE. (B)(4) CONTINUOUSLY MONITORS FOR THESE TYPES OF REPORTED COMPLICATIONS AND WILL CONTINUE TO DO SO. THIS REPORT WAS SUBMITTED TO MHRA AND CLOSED SEE ATTACHED REPORT AND CLOSURE LETTER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
382502 HEMOLUNG CATHETER KIT HEMOLUNG CATHETER KIT DQR ALUNG TECHNOLOGIES, INC. REF 30100

Patients

Seq Age Sex Outcome Treatment
1 52 YR Death